ZNF148 and metastatic malignant neoplasm in the lymph nodes: Moreover, ZNF148 act as a prognostic factor as its low expression is significantly associated to lymph node metastasis, poor differentiation, higher rate of disease recurrence, worse overall survival (OS) and shorter disease-free survival [45].